News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
China Resources Pharmaceutical (03320.HK) Subsidiary Nadroparin Calcium API Granted Marketing Approval
China Resources Pharmaceutical (03320.HK) announced that Tiandong Pharmaceutical, a subsidiary of the group, has received the "Notice of Approval for Marketing Application of Chemi...
Reset
Send
The window will close in 5 seconds
China Resources Pharmaceutical (03320.HK) Subsidiary Nadroparin Calcium API Granted Marketing Approval
Close
Recommend
4
Positive
2
Negative
1
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

China Resources Pharmaceutical (03320.HK)  -0.060 (-1.253%)    Short selling $1.79M; Ratio 5.609%   announced that Tiandong Pharmaceutical, a subsidiary of the group, has received the "Notice of Approval for Marketing Application of Chemical Active Pharmaceutical Ingredient" issued by the National Medical Products Administration for nadroparin calcium active pharmaceutical ingredient.

Nadroparin calcium is used for the treatment of established deep vein thrombosis; prevention of clot formation in the extracorporeal circulation during hemodialysis; in combination with aspirin for the treatment of unstable angina and the acute phase of non-Q-wave myocardial infarction; and for the prevention of venous thromboembolic disease in surgical patients at moderate or high risk of venous thrombosis. (ha/j)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-22 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.